JeffreySHeierMD
Ophthalmology • Boston, MARetinal Disease
Assistant Professor, Ophthalmology, Tufts Medical Center
Dr. Heier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
50 Staniford Street Suite 600
Ophthalmic Consultants of Boston
Boston, MA 02114Phone+1 800-635-0489- Is this information wrong?
Education & Training
Fitzsimons Army Medical CenterResidency, Ophthalmology, 1991 - 1994- Fitzsimons Army Medical CenterInternship, Transitional Year, 1989 - 1990
Boston University School of MedicineClass of 1989
Certifications & Licensure
MA State Medical License 1996 - 2024
RI State Medical License 1998 - 2004
PA State Medical License 1993 - 1998- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FAAO) American Academy of Ophthalmology
- Join now to see all
Clinical Trials
- Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. Start of enrollment: 2005 Dec 01
- Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser Start of enrollment: 2007 Jun 01
- A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy Start of enrollment: 2007 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Suprachoroidal Space Injection Technique: Expert Panel Guidance.Cunningham, E., Ciulla, T., Wykoff, C., Avery, R., Barakat, M., Boyer, D., Brown, D., Brucker, A., Heier, J., Holekamp, N., Kaiser, P., Khanani, A., Kim, J., Demirci, ...> ;Retina. 2024 Mar 5
- 1 citationsTENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.Arshad M Khanani, Aachal Kotecha, Andrew Chang, Shih-Jen Chen, Youxin Chen, Robyn Guymer, Jeffrey S Heier, Frank G Holz, Tomohiro Iida, Jane A Ives, Jennifer I Lim, Hu...> ;Ophthalmology. 2024 Feb 19
- Bispecific VEGF-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye Disease.Li Xu, Jessi R Prentice, Raul Velez-Montoya, Alina Sinha, Mark R Barakat, Ashwin Gupta, Robert Lowenthal, Arshad M Khanani, Peter K Kaiser, Jeffrey S Heier, Anthony Jo...> ;Ophthalmology Science. 2024 Jan 18
- Join now to see all
Press Mentions
Tips for Going Solo During a PandemicMarch 25th, 2022- Trials Show Promise for Intravitreal Faricimab in Retinal DiseaseFebruary 2nd, 2022
- 2020 on-Site Forms Industry and Scientific Advisory BoardJune 23rd, 2021
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
